Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Comment by yukoninvestoron Nov 25, 2012 7:08pm
166 Views
Post# 20641784

RE: Yukoninvestor

RE: Yukoninvestor

I think track record is key to most co's. If I am not mistaken Taku was a spawn of a rollback (CZM 3:1) and now with Taku at 70 million plus OS, burning through cash, soon in need of more money and sitting at 5c... In my opinion it is only a matter of time before they do another rollback. I am guessing one more financing (if they can get one) and then likely some more more wheel spinning exploration and voila history repeats itself.

I am not sure the YT is passe, but some of the stories are certainly getting a bit past prime in my opinion. Several companies and individuals were so hyped for a while, and then came the high priced financings, and now sp's are at fractions of the financing price, and I would guess there are now a whole suite of investors that roll their eyes and say next when they hear the name of one of these over-hyped entities. 

Costs may be high in the YT but they are high all across the world... beside a road in DRC... beside a village in the Peruvian Andes... in some drug lords backyard in Mexico... all very costly. 

Bullboard Posts